SCHEMBL5658335

SCHEMBL5658335

CN(C)C(=O)COc1ncc(C(=O)O)cn1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
ALDH1A1 P00352 4/20 0.50
HSD17B10 Q99714 4/20 0.50
ALOX15 P16050 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.45
MAPT P10636 1/20 0.44
HCAR3 P49019 3/20 0.40
POLB P06746 2/20 0.39
KEAP1 Q14145 3/20 0.38
NFE2L2 Q16236 3/20 0.38
SRD5A2 P31213 1/20 0.38
HPGD P15428 3/20 0.38
P4HA1 P13674 1/20 0.36
P4HTM Q9NXG6 1/20 0.36
PLA2G4B P0C869 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5657170 0.85 KDM4E (0.46) KDM4EALDH1A1HSD17B10ALOX15SMN1; SMN2
SCHEMBL5660200 0.82 KMT2A (0.51) KDM4EALDH1A1HSD17B10ALOX15SMN1; SMN2
SCHEMBL186124 0.80 MAPT (0.59) KDM4EALDH1A1HSD17B10ALOX15MAPT
SCHEMBL5660559 0.77 MAPT (0.45) KDM4EALDH1A1HSD17B10ALOX15MAPT
SCHEMBL6538720 0.74 SMN1; SMN2 (0.68) SMN1; SMN2KEAP1NFE2L2SRD5A2PLA2G4B
SCHEMBL15514113 0.71 HCAR3 (0.50) KDM4EALDH1A1HSD17B10ALOX15MAPT
SCHEMBL26704132 0.71 ALDH1A1 (0.44) KDM4EALDH1A1HSD17B10ALOX15MAPT
SCHEMBL15505042 0.71 XDH (0.50) KDM4EALDH1A1HSD17B10ALOX15MAPT
SCHEMBL185428 0.71 KDM4E (0.52) KDM4EALDH1A1HSD17B10ALOX15MAPT
SCHEMBL23405915 0.71 KEAP1 (0.45) KDM4EHSD17B10SMN1; SMN2POLBKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7176310-B1 Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents UCB SA (GB) 2007-02-13 US disclosed